Reporting outcomes to better inform and improve care for cancer patients
Many patients living with a metastatic cancer diagnosis struggle with the trade-offs between and possible benefits and harms of treatment options when they know that the treatment will not lead to a cure. This dilemma is worsened by a lack of information on whether the order and timing of giving different treatments makes a difference in terms of benefits, cumulative toxicities, out-of-pocket cost, quality of life, and other concerns. The GPC Oncology Consortium developed recommendations for methods to help researchers compare sequences of treatment to measure and report on the outcomes that matter to these patients, such as the impact of the treatment side effects, or the ability to maintain a work schedule. The team envisions that future studies comparing sequences of cancer treatments can help better inform patients and their caregivers, and help with their treatment decisions.